Primetime Editorial

Clearmind Medicine

Clearmind Medicine Inc. Accelerates Mission To Make History With Psychedelic-Based Therapeutics ($CMND) 

Weakness in Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) stock is less a trend than it is an opportunity. In fact, the decline in value over the past two weeks may be well overdone, noting that a series of milestones reached, patents earned, and valuable partnerships ideally position CMND to have its best year in

Clearmind Medicine Inc. Accelerates Mission To Make History With Psychedelic-Based Therapeutics ($CMND)  Read More »

Safe-T Group

Safe-T Group Ltd. Stock Turns Bullish As Record-Setting Revenues Draw Investor Interest ($SFET)

Safe-T Group Ltd. (NASDAQ, TASE: SFET) stock is turning bullish, with investors hanging around into the last week of 2022 scooping up shares of this innovative and global provider of cyber-security and privacy solutions to consumers and enterprises. Currently, SFET stock is higher by about 7% compared to the lows set last week. And based

Safe-T Group Ltd. Stock Turns Bullish As Record-Setting Revenues Draw Investor Interest ($SFET) Read More »

Clearmind Medicine

Clearmind Medicine Inc. Is Blazing A Trail For Psychedelic-Based Treatment For AUD ($CMND)

Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) is blazing an innovative trail, positioning to deliver a first-to-market psychedelic-based treatment targeting Alcohol Use Disorder (AUD). That proposition just got stronger. Last week, CMND announced earning yet another patent from the United States Patent and Trademark Office (USPTO), this one protecting its proprietary MEAI as an alcoholic

Clearmind Medicine Inc. Is Blazing A Trail For Psychedelic-Based Treatment For AUD ($CMND) Read More »

Siyata Mobile

Siyata Mobile Stock Turns Bullish After Two Carrier Deals And A 588% Surge In Q3 Revenues ($SYTA)

It pays to be different in crowded sectors, and Siyata Mobile (NASDAQ: SYTA) is proving that point. In fact, SYTA’s standout characteristics have been instrumental in the pursuit of its mission to secure a global market leadership position in the fast-growing Push-to-Talk Over Cellular (PoC) sector. Thus, don’t be misled by the company’s micro-cap share

Siyata Mobile Stock Turns Bullish After Two Carrier Deals And A 588% Surge In Q3 Revenues ($SYTA) Read More »

Clearmind Medicine

Clearmind Medicine Inc. Shares Surge After Reaching Key Milestones Expediting Marketing Of Psychedelic-Based Treatments($CMND)

The times are changing, and so are the ways chronic conditions can be treated. The relentless lineup of side-effect-laden pharmaceuticals is no longer the only therapeutic option when treating debilitating physical and mental disorders. Better, safer, and more manageable ways of treatment are emerging, disrupting the pharmaceutical landscape and exposing investment opportunities in companies intent

Clearmind Medicine Inc. Shares Surge After Reaching Key Milestones Expediting Marketing Of Psychedelic-Based Treatments($CMND) Read More »

AppTech Payments

AppTech Payments Corp Shares Are Skyrocketing Up 88% In December Here’s Why ($APCX)

AppTech Payments Corp. (NASDAQ: APCX) stock is on fire. On Thursday, APCX stock soared about 41%, adding to its week long rally. Shares are currently trading at $1.66, 88% higher from where they started the month.The leading contributor is that AppTech has positioned itself well to stake its claim as one of the most innovative

AppTech Payments Corp Shares Are Skyrocketing Up 88% In December Here’s Why ($APCX) Read More »

Avalon GloboCare

Avalon GloboCare Strengthens Balance Sheet After $4.0 Million Private Placement Priced At A Premium ($ALBT)

Shares of Avalon GloboCare (NASDAQ: ALBT) have been trending higher. Since December 12th, ALBT stock is over 40% higher, with shares trading today at roughly $0.45 on Friday. News from Avalon last Wednesday provided a solid reason for the bullish sentiment, showing that ALBT’s intention of becoming a more prominent company is happening faster than

Avalon GloboCare Strengthens Balance Sheet After $4.0 Million Private Placement Priced At A Premium ($ALBT) Read More »

Kaival Brands

Kaival Brands Is Positioned For A Massive 2023 Breakout, Here’s Why ($KAVL)

Kaival Brands International (NASDAQ: KAVL) stock may be volatile in December, but make no mistake, they are one of the last electronic nicotine device system (ENDS) sector companies standing in a sector worth potentially billions in revenues. That results from KAVL earning a stay of order from a U.S. District Court that allows KAVL the

Kaival Brands Is Positioned For A Massive 2023 Breakout, Here’s Why ($KAVL) Read More »

Mainz Biomed

Kaival Brands Stock Attractive; Partnerships, Court Wins, And Bidi Vapor Drives Interest ($KAVL)

Kaival Brands International (NASDAQ: KAVL) is on a roll. And a series of updates shows that its business momentum is far from slowing. In fact, quite the opposite. KAVL stock is higher by over 40% YTD, they have inked a major partnership with tobacco industry giant Philip Morris (NYSE: PM), earned a stay of order

Kaival Brands Stock Attractive; Partnerships, Court Wins, And Bidi Vapor Drives Interest ($KAVL) Read More »

Avalon GloboCare Partnerships And Planned Acquisition Fuel Bullish Interest ($ALBT)

Thinly traded Avalon GloboCare (NASDAQ: ALBT) stock is in play. In fact, shares moved more than 5% higher last week, touching $0.38 on higher-than-normal volume. By the way, calling ALBT shares “thinly traded” doesn’t imply that they are entirely under the radar. They certainly aren’t, as the average three-month volume before risk-off markets shows shares

Avalon GloboCare Partnerships And Planned Acquisition Fuel Bullish Interest ($ALBT) Read More »